BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

794 related articles for article (PubMed ID: 28030747)

  • 1. Factors Associated With and Prognostic Implications of Cardiac Troponin Elevation in Decompensated Heart Failure With Preserved Ejection Fraction: Findings From the American Heart Association Get With The Guidelines-Heart Failure Program.
    Pandey A; Golwala H; Sheng S; DeVore AD; Hernandez AF; Bhatt DL; Heidenreich PA; Yancy CW; de Lemos JA; Fonarow GC
    JAMA Cardiol; 2017 Feb; 2(2):136-145. PubMed ID: 28030747
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The prognostic value of highly sensitive cardiac troponin assays for adverse events in men and women with stable heart failure and a preserved vs. reduced ejection fraction.
    Gohar A; Chong JPC; Liew OW; den Ruijter H; de Kleijn DPV; Sim D; Yeo DPS; Ong HY; Jaufeerally F; Leong GKT; Ling LH; Lam CSP; Richards AM
    Eur J Heart Fail; 2017 Dec; 19(12):1638-1647. PubMed ID: 28849609
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pre-discharge and early post-discharge troponin elevation among patients hospitalized for heart failure with reduced ejection fraction: findings from the ASTRONAUT trial.
    Greene SJ; Butler J; Fonarow GC; Subacius HP; Ambrosy AP; Vaduganathan M; Triggiani M; Solomon SD; Lewis EF; Maggioni AP; Böhm M; Chioncel O; Nodari S; Senni M; Zannad F; Gheorghiade M;
    Eur J Heart Fail; 2018 Feb; 20(2):281-291. PubMed ID: 29044915
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of characteristics and outcomes of patients with heart failure preserved ejection fraction versus reduced left ventricular ejection fraction in an urban cohort.
    Quiroz R; Doros G; Shaw P; Liang CS; Gauthier DF; Sam F
    Am J Cardiol; 2014 Feb; 113(4):691-6. PubMed ID: 24484862
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Outcomes of patients with anemia and acute decompensated heart failure with preserved versus reduced ejection fraction (from the ARIC study community surveillance).
    Caughey MC; Avery CL; Ni H; Solomon SD; Matsushita K; Wruck LM; Rosamond WD; Loehr LR
    Am J Cardiol; 2014 Dec; 114(12):1850-4. PubMed ID: 25438912
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Recurrent Acute Decompensated Heart Failure Admissions for Patients With Reduced Versus Preserved Ejection Fraction (from the Atherosclerosis Risk in Communities Study).
    Caughey MC; Sueta CA; Stearns SC; Shah AM; Rosamond WD; Chang PP
    Am J Cardiol; 2018 Jul; 122(1):108-114. PubMed ID: 29703442
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic impacts of changes in left ventricular ejection fraction in heart failure patients with preserved left ventricular ejection fraction.
    Yoshihisa A; Sato Y; Kanno Y; Takiguchi M; Yokokawa T; Abe S; Misaka T; Sato T; Oikawa M; Kobayashi A; Yamaki T; Kunii H; Takeishi Y
    Open Heart; 2020; 7(1):e001112. PubMed ID: 32341787
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association Between Circulating Troponin Concentrations, Left Ventricular Systolic and Diastolic Functions, and Incident Heart Failure in Older Adults.
    Myhre PL; Claggett B; Ballantyne CM; Selvin E; Røsjø H; Omland T; Solomon SD; Skali H; Shah AM
    JAMA Cardiol; 2019 Oct; 4(10):997-1006. PubMed ID: 31483438
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevalence and prognostic impact of non-cardiac co-morbidities in heart failure outpatients with preserved and reduced ejection fraction: a community-based study.
    Iorio A; Senni M; Barbati G; Greene SJ; Poli S; Zambon E; Di Nora C; Cioffi G; Tarantini L; Gavazzi A; Sinagra G; Di Lenarda A
    Eur J Heart Fail; 2018 Sep; 20(9):1257-1266. PubMed ID: 29917301
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Systolic Blood Pressure and Outcomes in Patients With Heart Failure With Preserved Ejection Fraction.
    Tsimploulis A; Lam PH; Arundel C; Singh SN; Morgan CJ; Faselis C; Deedwania P; Butler J; Aronow WS; Yancy CW; Fonarow GC; Ahmed A
    JAMA Cardiol; 2018 Apr; 3(4):288-297. PubMed ID: 29450487
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic significance of high-sensitivity cardiac troponin in patients with heart failure with preserved ejection fraction.
    Suzuki S; Motoki H; Minamisawa M; Okuma Y; Shoin W; Okano T; Kimura K; Ebisawa S; Okada A; Kuwahara K
    Heart Vessels; 2019 Oct; 34(10):1650-1656. PubMed ID: 30929038
    [TBL] [Abstract][Full Text] [Related]  

  • 12. BNP and obesity in acute decompensated heart failure with preserved vs. reduced ejection fraction: The Atherosclerosis Risk in Communities Surveillance Study.
    Khalid U; Wruck LM; Quibrera PM; Bozkurt B; Nambi V; Virani SS; Jneid H; Agarwal S; Chang PP; Loehr L; Basra SS; Rosamond W; Ballantyne CM; Deswal A
    Int J Cardiol; 2017 Apr; 233():61-66. PubMed ID: 28185703
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cardiac troponin and outcome in decompensated heart failure with preserved ejection fraction.
    Thawabi M; Hawatmeh A; Studyvin S; Habib H; Shamoon F; Cohen M
    Cardiovasc Diagn Ther; 2017 Aug; 7(4):359-366. PubMed ID: 28890872
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Short-term outcomes of heart failure patients with reduced and preserved ejection fraction after acute decompensation according to the final destination after emergency department care.
    Miró Ò; Gil VÍ; Martín-Sánchez FJ; Jacob J; Herrero P; Alquézar A; Llauger L; Aguiló S; Martínez G; Ríos J; Domínguez-Rodríguez A; Harjola VP; Müller C; Parissis J; Peacock WF; Llorens P;
    Clin Res Cardiol; 2018 Aug; 107(8):698-710. PubMed ID: 29594372
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A comprehensive population-based characterization of heart failure with mid-range ejection fraction.
    Koh AS; Tay WT; Teng THK; Vedin O; Benson L; Dahlstrom U; Savarese G; Lam CSP; Lund LH
    Eur J Heart Fail; 2017 Dec; 19(12):1624-1634. PubMed ID: 28948683
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic significance of hyponatremia among ambulatory patients with heart failure and preserved and reduced ejection fractions.
    Bavishi C; Ather S; Bambhroliya A; Jneid H; Virani SS; Bozkurt B; Deswal A
    Am J Cardiol; 2014 Jun; 113(11):1834-8. PubMed ID: 24837261
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rate pressure product and the components of heart rate and systolic blood pressure in hospitalized heart failure patients with preserved ejection fraction: Insights from ASCEND-HF.
    Verma AK; Sun JL; Hernandez A; Teerlink JR; Schulte PJ; Ezekowitz J; Voors A; Starling R; Armstrong P; O'Conner CM; Mentz RJ
    Clin Cardiol; 2018 Jul; 41(7):945-952. PubMed ID: 29781109
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In-Hospital and Three-Year Outcomes of Heart Failure Patients in South India: The Trivandrum Heart Failure Registry.
    Sanjay G; Jeemon P; Agarwal A; Viswanathan S; Sreedharan M; Vijayaraghavan G; Bahuleyan CG; Biju R; Nair T; Prathapkumar N; Krishnakumar G; Rajalekshmi N; Suresh K; Park LP; Huffman MD; Harikrishnan S
    J Card Fail; 2018 Dec; 24(12):842-848. PubMed ID: 29885494
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Outcomes in patients with heart failure with preserved, borderline, and reduced ejection fraction in the Medicare population.
    Cheng RK; Cox M; Neely ML; Heidenreich PA; Bhatt DL; Eapen ZJ; Hernandez AF; Butler J; Yancy CW; Fonarow GC
    Am Heart J; 2014 Nov; 168(5):721-30. PubMed ID: 25440801
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High-Sensitivity Troponin I in Hospitalized and Ambulatory Patients With Heart Failure With Preserved Ejection Fraction: Insights From the Heart Failure Clinical Research Network.
    Fudim M; Ambrosy AP; Sun JL; Anstrom KJ; Bart BA; Butler J; AbouEzzeddine O; Greene SJ; Mentz RJ; Redfield MM; Reddy YNV; Vaduganathan M; Braunwald E; Hernandez AF; Borlaug BA; Felker GM
    J Am Heart Assoc; 2018 Dec; 7(24):e010364. PubMed ID: 30561266
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 40.